Ardent Health appoints Dave Caspers as CEO, reaffirms FY 2026 EBITDA guidance

Ardent Health, Inc.

Dave Caspers appointed President and CEO, effective June 2, 2026, succeeding Marty Bonick.
Caspers receives $900k base salary, 105% target bonus, RSUs ($1.05M) and PRSUs ($1.95M target).
Company reaffirms FY 2026 Adjusted EBITDA guidance of $485M-$535M despite Q2 volume softness.
CFO says Q2 volume softness observed; IMPACT program accelerated to improve margins.
Caspers also appointed to Board of Directors.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Martin J. Bonick

Chief Executive Officer

ARDT · Ardent Health, Inc.

Effective: 2026-06-02
Successor: Dave Caspers
Filed: June 2, 2026, 4:23 PM ET

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

Appointed

Dave Caspers

President and Chief Executive Officer

ARDT · Ardent Health, Inc.

Effective: 2026-06-02
Filed: June 2, 2026, 4:23 PM ET

On June 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Ardent Health, Inc. (the “Company”) appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Martin J. Bonick departed as Chief Executive Officer at Ardent Health, Inc..

Action: separated
Role: Chief Executive Officer

Exact text from the filing

Mr. Caspers succeeds Martin J. Bonick, who separated from the Company and stepped down from the Board effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dave Caspers was appointed as President and Chief Executive Officer at Ardent Health, Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

On June 2, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Ardent Health, Inc. (the “Company”) appointed Dave Caspers, who previously served as the Company’s Chief Operating Officer, as the Company’s President and Chief Executive Officer and as a member of the Board.

View on SEC.gov

Ardent Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-253567

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.